Invention Application
- Patent Title: ANTI-CANCER GOLD COMPOUNDS
-
Application No.: US17595019Application Date: 2020-05-07
-
Publication No.: US20220204538A1Publication Date: 2022-06-30
- Inventor: Nedaossadat MIRZADEH , Suresh BHARGAVA , Steven PRIVER , Srinivasa Reddy TELUKUTLA
- Applicant: Royal Melbourne Institute of Technology
- Applicant Address: AU Melbourne, Victoria
- Assignee: Royal Melbourne Institute of Technology
- Current Assignee: Royal Melbourne Institute of Technology
- Current Assignee Address: AU Melbourne, Victoria
- Priority: AU2019901547 20190507
- International Application: PCT/AU2020/050451 WO 20200507
- Main IPC: C07F9/53
- IPC: C07F9/53 ; A61P35/00 ; C07F1/02

Abstract:
A compound according to Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1 and R2 are each independently selected from optionally substituted C1-6-alkyl and optionally substituted aryl; R3, R4, R5, and R6 are each independently selected from the group consisting of H, halo, optionally substituted C1-6-alkyl, and optionally substituted C1-6 alkoxy; and R7 is a phosphorus containing moiety, wherein a phosphorus atom is bonded to Au.
Public/Granted literature
- US12152047B2 Anti-cancer gold compounds Public/Granted day:2024-11-26
Information query